176 related articles for article (PubMed ID: 15456958)
1. Oligonucleotide decoy mimicking alphaA-crystallin-binding protein 1 binding site on mouse Col2a1 enhancer stimulates transcription from the adjacent Col2a1 promoter in chondrogenic ATDC5 cell.
Yamagiwa H; Yamada Y; Bolander ME; Sarkar G
Mol Biotechnol; 2004 Sep; 28(1):1-8. PubMed ID: 15456958
[TBL] [Abstract][Full Text] [Related]
2. A zinc finger transcription factor, alphaA-crystallin binding protein 1, is a negative regulator of the chondrocyte-specific enhancer of the alpha1(II) collagen gene.
Tanaka K; Matsumoto Y; Nakatani F; Iwamoto Y; Yamada Y
Mol Cell Biol; 2000 Jun; 20(12):4428-35. PubMed ID: 10825206
[TBL] [Abstract][Full Text] [Related]
3. SOX9 exerts a bifunctional effect on type II collagen gene (COL2A1) expression in chondrocytes depending on the differentiation state.
Kypriotou M; Fossard-Demoor M; Chadjichristos C; Ghayor C; de Crombrugghe B; Pujol JP; Galéra P
DNA Cell Biol; 2003 Feb; 22(2):119-29. PubMed ID: 12713737
[TBL] [Abstract][Full Text] [Related]
4. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo.
Zhou G; Lefebvre V; Zhang Z; Eberspaecher H; de Crombrugghe B
J Biol Chem; 1998 Jun; 273(24):14989-97. PubMed ID: 9614106
[TBL] [Abstract][Full Text] [Related]
5. ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity.
Otero M; Peng H; Hachem KE; Culley KL; Wondimu EB; Quinn J; Asahara H; Tsuchimochi K; Hashimoto K; Goldring MB
Connect Tissue Res; 2017 Jan; 58(1):15-26. PubMed ID: 27310669
[TBL] [Abstract][Full Text] [Related]
6. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer.
Bridgewater LC; Lefebvre V; de Crombrugghe B
J Biol Chem; 1998 Jun; 273(24):14998-5006. PubMed ID: 9614107
[TBL] [Abstract][Full Text] [Related]
7. Sp1 and Sp3 transcription factors mediate interleukin-1 beta down-regulation of human type II collagen gene expression in articular chondrocytes.
Chadjichristos C; Ghayor C; Kypriotou M; Martin G; Renard E; Ala-Kokko L; Suske G; de Crombrugghe B; Pujol JP; Galéra P
J Biol Chem; 2003 Oct; 278(41):39762-72. PubMed ID: 12888570
[TBL] [Abstract][Full Text] [Related]
8. SOX9 expression does not correlate with type II collagen expression in adult articular chondrocytes.
Aigner T; Gebhard PM; Schmid E; Bau B; Harley V; Pöschl E
Matrix Biol; 2003 Jun; 22(4):363-72. PubMed ID: 12935820
[TBL] [Abstract][Full Text] [Related]
9. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-gamma-mediated inhibition in human chondrocytes: requirement for Stat1 alpha, Jak1 and Jak2.
Osaki M; Tan L; Choy BK; Yoshida Y; Cheah KS; Auron PE; Goldring MB
Biochem J; 2003 Jan; 369(Pt 1):103-15. PubMed ID: 12223098
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site.
Akiyama H; Kamitani T; Yang X; Kandyil R; Bridgewater LC; Fellous M; Mori-Akiyama Y; de Crombrugghe B
Matrix Biol; 2005 Jan; 23(8):499-505. PubMed ID: 15694126
[TBL] [Abstract][Full Text] [Related]
11. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.
Lefebvre V; Huang W; Harley VR; Goodfellow PN; de Crombrugghe B
Mol Cell Biol; 1997 Apr; 17(4):2336-46. PubMed ID: 9121483
[TBL] [Abstract][Full Text] [Related]
12. Mint represses transactivation of the type II collagen gene enhancer through interaction with alpha A-crystallin-binding protein 1.
Yang X; Li J; Qin H; Yang H; Li J; Zhou P; Liang Y; Han H
J Biol Chem; 2005 May; 280(19):18710-6. PubMed ID: 15778499
[TBL] [Abstract][Full Text] [Related]
13. Regulation of type-II collagen gene expression during human chondrocyte de-differentiation and recovery of chondrocyte-specific phenotype in culture involves Sry-type high-mobility-group box (SOX) transcription factors.
Stokes DG; Liu G; Dharmavaram R; Hawkins D; Piera-Velazquez S; Jimenez SA
Biochem J; 2001 Dec; 360(Pt 2):461-70. PubMed ID: 11716775
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of different conditions for ligating dumbbell-shaped oligonucleotides.
Yamagiwa H; Bolander ME; Sarkar G
Mol Biotechnol; 2004 Feb; 26(2):111-6. PubMed ID: 14764936
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylation of SOX9 by cyclic AMP-dependent protein kinase A enhances SOX9's ability to transactivate a Col2a1 chondrocyte-specific enhancer.
Huang W; Zhou X; Lefebvre V; de Crombrugghe B
Mol Cell Biol; 2000 Jun; 20(11):4149-58. PubMed ID: 10805756
[TBL] [Abstract][Full Text] [Related]
16. A new long form of c-Maf cooperates with Sox9 to activate the type II collagen gene.
Huang W; Lu N; Eberspaecher H; De Crombrugghe B
J Biol Chem; 2002 Dec; 277(52):50668-75. PubMed ID: 12381733
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5.
Hattori T; Coustry F; Stephens S; Eberspaecher H; Takigawa M; Yasuda H; de Crombrugghe B
Nucleic Acids Res; 2008 May; 36(9):3011-24. PubMed ID: 18390577
[TBL] [Abstract][Full Text] [Related]
18. Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements.
Bridgewater LC; Walker MD; Miller GC; Ellison TA; Holsinger LD; Potter JL; Jackson TL; Chen RK; Winkel VL; Zhang Z; McKinney S; de Crombrugghe B
Nucleic Acids Res; 2003 Mar; 31(5):1541-53. PubMed ID: 12595563
[TBL] [Abstract][Full Text] [Related]
19. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer.
Han Y; Lefebvre V
Mol Cell Biol; 2008 Aug; 28(16):4999-5013. PubMed ID: 18559420
[TBL] [Abstract][Full Text] [Related]
20. Induction of the Sry-related factor SOX6 contributes to bone morphogenetic protein-2-induced chondroblastic differentiation of C3H10T1/2 cells.
Fernández-Lloris R; Viñals F; López-Rovira T; Harley V; Bartrons R; Rosa JL; Ventura F
Mol Endocrinol; 2003 Jul; 17(7):1332-43. PubMed ID: 12677004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
